Literature DB >> 28271489

The Pyruvate Dehydrogenase Complex and Related Assemblies in Health and Disease.

Olwyn Byron1, John Gordon Lindsay2.   

Abstract

The family of 2-oxoacid dehydrogenase complexes (2-OADC), typified by the pyruvate dehydrogenase multi-enzyme complex (PDC) as its most prominent member, are massive molecular machines (Mr, 4-10 million) controlling key steps in glucose homeostasis (PDC), citric acid cycle flux (OGDC, 2-oxoglutarate dehydrogenase) and the metabolism of the branched-chain amino acids, leucine, isoleucine and valine (BCOADC, branched-chain 2-OADC). These highly organised mitochondrial arrays, composed of multiple copies of three separate enzymes, have been widely studied as paradigms for the analysis of enzyme cooperativity, substrate channelling, protein-protein interactions and the regulation of activity by phosphorylation . This chapter will highlight recent advances in our understanding of the structure-function relationships, the overall organisation and the transport and assembly of PDC in particular, focussing on both native and recombinant forms of the complex and their individual components or constituent domains. Biophysical approaches, including X-ray crystallography (MX), nuclear magnetic resonance spectroscopy (NMR), cryo-EM imaging, analytical ultracentrifugation (AUC) and small angle X-ray and neutron scattering (SAXS and SANS), have all contributed significant new information on PDC subunit organisation, stoichiometry, regulatory mechanisms and mode of assembly. Moreover, the recognition of specific genetic defects linked to PDC deficiency, in combination with the ability to analyse recombinant PDCs housing both novel naturally-occurring and engineered mutations, have all stimulated renewed interest in these classical metabolic assemblies. In addition, the role played by PDC, and its constituent proteins, in certain disease states will be briefly reviewed, focussing on the development of new and exciting areas of medical and immunological research.

Entities:  

Keywords:  Biophysical characterisation; Genetic defects; Intracellular trafficking; PDC deficiency; Phosphorylation; Potential drug target; Pyruvate dehydrogenase complex; Reaction cycle; Structure-function relationship; Supramolecular architecture

Mesh:

Substances:

Year:  2017        PMID: 28271489     DOI: 10.1007/978-3-319-46503-6_19

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  8 in total

1.  A multipronged approach unravels unprecedented protein-protein interactions in the human 2-oxoglutarate dehydrogenase multienzyme complex.

Authors:  Jieyu Zhou; Luying Yang; Oliver Ozohanics; Xu Zhang; Junjie Wang; Attila Ambrus; Palaniappa Arjunan; Roman Brukh; Natalia S Nemeria; William Furey; Frank Jordan
Journal:  J Biol Chem       Date:  2018-10-15       Impact factor: 5.157

2.  Pyruvate dehydrogenase complex deficiency is linked to regulatory loop disorder in the αV138M variant of human pyruvate dehydrogenase.

Authors:  Matthew J Whitley; Palaniappa Arjunan; Natalia S Nemeria; Lioubov G Korotchkina; Yun-Hee Park; Mulchand S Patel; Frank Jordan; William Furey
Journal:  J Biol Chem       Date:  2018-07-03       Impact factor: 5.157

3.  Actinobacteria challenge the paradigm: A unique protein architecture for a well-known, central metabolic complex.

Authors:  Eduardo M Bruch; Pierre Vilela; Lu Yang; Alexandra Boyko; Norik Lexa-Sapart; Bertrand Raynal; Pedro M Alzari; Marco Bellinzoni
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

4.  Structure-function analyses of the G729R 2-oxoadipate dehydrogenase genetic variant associated with a disorder of l-lysine metabolism.

Authors:  Xu Zhang; Natalia S Nemeria; João Leandro; Sander Houten; Michael Lazarus; Gary Gerfen; Oliver Ozohanics; Attila Ambrus; Balint Nagy; Roman Brukh; Frank Jordan
Journal:  J Biol Chem       Date:  2020-04-17       Impact factor: 5.157

5.  Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism.

Authors:  Andrea L Gropman; Afrouz Anderson
Journal:  J Transl Genet Genom       Date:  2020-11-13

Review 6.  Novel Candidates for Vaccine Development Against Mycoplasma Capricolum Subspecies Capripneumoniae (Mccp)-Current Knowledge and Future Prospects.

Authors:  Mohd Iqbal Yatoo; Oveas Raffiq Parray; Riyaz Ahmed Bhat; Qurat Un Nazir; Abrar Ul Haq; Hamid Ullah Malik; Mujeeb Ur Rehman Fazilli; Arumugam Gopalakrishnan; Shah Tauseef Bashir; Ruchi Tiwari; Sandip Kumar Khurana; Wanpen Chaicumpa; Kuldeep Dhama
Journal:  Vaccines (Basel)       Date:  2019-07-23

7.  How phosphorylation influences E1 subunit pyruvate dehydrogenase: A computational study.

Authors:  Jacopo Sgrignani; JingJing Chen; Andrea Alimonti; Andrea Cavalli
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

8.  Pyruvate dehydrogenase complex deficiency: updating the clinical, metabolic and mutational landscapes in a cohort of Portuguese patients.

Authors:  Hana Pavlu-Pereira; Maria João Silva; Cristina Florindo; Sílvia Sequeira; Ana Cristina Ferreira; Sofia Duarte; Ana Luísa Rodrigues; Patrícia Janeiro; Anabela Oliveira; Daniel Gomes; Anabela Bandeira; Esmeralda Martins; Roseli Gomes; Sérgia Soares; Isabel Tavares de Almeida; João B Vicente; Isabel Rivera
Journal:  Orphanet J Rare Dis       Date:  2020-10-22       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.